HDAC6 and prostate cancer: HDAC6 is overexpressed in several cancers such as breast cancer [13], pancreatic cancer [12], prostate cancer, ovarian cancer, myeloid leukemia [10], B and T cell lymphomas [14], glioblastoma [15], oral squamous cell carcinoma [16], bladder cancer, and lung cancer [12].